As of January 22, 2025, Editas Medicine (EDIT) has a market cap of $0.11 billion USD. According to our data, Editas Medicine is ranked No.7606 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 22, 2025 | $0.11 B |
5.91%
|
Dec 31, 2024 | $0.10 B |
-87.46%
|
Dec 29, 2023 | $0.84 B |
14.21%
|
Dec 30, 2022 | $0.73 B |
-66.59%
|
Dec 31, 2021 | $2.19 B |
-62.13%
|
Dec 31, 2020 | $5.79 B |
136.78%
|
Dec 31, 2019 | $2.44 B |
30.15%
|
Dec 31, 2018 | $1.88 B |
-25.97%
|
Dec 29, 2017 | $2.54 B |
89.34%
|
Dec 30, 2016 | $1.34 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Intellia Therapeutics
NTLA
|
$1.11 B |
-0.000 M
|
USA
|
Editas Medicine
EDIT
|
$0.11 B |
0.000 M
|
USA
|
Beam Therapeutics
BEAM
|
$2.19 B |
0.000 M
|
USA
|
Sangamo Therapeutics
SGMO
|
$0.24 B |
0.000 M
|
USA
|
bluebird bio
BLUE
|
$77.49 M |
-0.000 M
|
USA
|
REGENXBIO
RGNX
|
$0.38 B |
0.000 M
|
USA
|
Precision BioSciences
DTIL
|
$38.43 M |
0.000 M
|
USA
|
Cellectis
CLLS
|
$0.16 B |
4.659 M
|
France
|
Allogene Therapeutics
ALLO
|
$0.40 B |
0.000 M
|
USA
|
Sana Biotechnology
SANA
|
$0.79 B |
1.116 M
|
USA
|
Verve Therapeutics
VERV
|
$0.67 B |
0.000 M
|
USA
|
Market Cap | = | EDIT Stock Price | * | EDIT Shares Outstanding |
= | $1.35 | * | 82.55 M | |
= | $0.11 B |